Baxter International Appoints Blake E. Devitt to Board of Directors
Blake E. Devitt, a seasoned auditor and industry expert with 33 years of experience at Ernst & Young LLP, has been appointed to Baxter International's board of directors. Devitt, who recently retired as senior audit partner and leader of the pharmaceutical and medical device industry practice, brings a unique blend of accounting, finance, and industry expertise to the board. His extensive experience working with top pharmaceutical and medical device clients, including Eli Lilly and Company and Guidant Corporation, will provide valuable insights and perspectives. Devitt's appointment is seen as a significant addition to the board, given his familiarity with the industry and his extensive background in accounting and finance.
Key Takeaways:
- Devitt brings 33 years of experience to Baxter International's board of directors, including 4 years as leader of Ernst & Young's advisory services for global pharmaceutical companies.
- He served as lead partner on several of the firm's largest pharmaceutical and medical device audit clients, including Eli Lilly and Company and Guidant Corporation.
- Devitt's experience working with top industry clients will provide valuable insights and perspectives to the board.
- He brings a master's degree in business administration from the University of Wisconsin (Madison) and a bachelor's degree in accounting from Bradley University in Peoria, Ill.
- Devitt's appointment is seen as a significant addition to the board, given his familiarity with the industry and his extensive background in accounting and finance.
Statistics:
- 33 years: length of Devitt's career at Ernst & Young LLP
- 4 years: length of time Devitt led Ernst & Young's advisory services for global pharmaceutical companies
- 2: number of degrees held by Devitt (bachelor's in accounting and master's in business administration)
- 2: number of major pharmaceutical and medical device clients Devitt led audits for at Ernst & Young (Eli Lilly and Company and Guidant Corporation)
Sources:
- Baxter International, Inc. press release
- Health & Medicine Week, via NewsRx.com
- Robert L. Parkinson, Jr., chairman and chief executive officer of Baxter International, cited in press release